Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 266

1.

Mycosis fungoides and Sezary syndrome.

Diamandidou E, Cohen PR, Kurzrock R.

Blood. 1996 Oct 1;88(7):2385-409. Review. No abstract available.

2.

[Cutaneous T-cell lymphoma].

Dippel E, Gellrich S, Klemke CD, Goerdt S, Sterry W.

J Dtsch Dermatol Ges. 2003 Dec;1(12):965-80; quiz 981-2. Review. German. No abstract available.

PMID:
16285650
3.

Mycosis fungoides and the Sézary syndrome: a review of pathogenesis, diagnosis, and therapy.

Kuzel TM, Roenigk HH Jr, Rosen ST.

J Clin Oncol. 1991 Jul;9(7):1298-313. Review.

PMID:
2045869
4.
5.

Treatment of mycosis fungoides/Sezary syndrome: the University of California, San Francisco (UCSF) approach.

Zackheim HS.

Int J Dermatol. 2003 Jan;42(1):53-6. Review. No abstract available.

PMID:
12581145
6.

Mycosis fungoides and the Sézary syndrome.

Kim YH, Hoppe RT.

Semin Oncol. 1999 Jun;26(3):276-89. Review.

PMID:
10375085
7.

Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome).

Wong HK, Mishra A, Hake T, Porcu P.

Br J Haematol. 2011 Oct;155(2):150-66. doi: 10.1111/j.1365-2141.2011.08852.x. Epub 2011 Aug 25. Review.

8.

Review of the treatment of mycosis fungoides and sézary syndrome: a stage-based approach.

Horwitz SM, Olsen EA, Duvic M, Porcu P, Kim YH.

J Natl Compr Canc Netw. 2008 Apr;6(4):436-42. Review.

PMID:
18433609
9.

Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.

Edelson RL.

J Am Acad Dermatol. 1980 Feb;2(2):89-106. Review.

PMID:
6988470
10.
11.

Mycosis fungoides.

Gaeke ME, Variakojis D, Sweet DL.

Curr Probl Cancer. 1981 Sep;6(3):1-39. No abstract available.

PMID:
7285618
12.

Cutaneous T-cell lymphoma.

Lansigan F, Choi J, Foss FM.

Hematol Oncol Clin North Am. 2008 Oct;22(5):979-96, x. doi: 10.1016/j.hoc.2008.07.014. Review.

PMID:
18954747
13.

Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.

Fraser-Andrews EA, Mitchell T, Ferreira S, Seed PT, Russell-Jones R, Calonje E, Whittaker SJ.

Br J Dermatol. 2006 Oct;155(4):756-62.

PMID:
16965425
14.

The spectrum of hair loss in patients with mycosis fungoides and Sézary syndrome.

Bi MY, Curry JL, Christiano AM, Hordinsky MK, Norris DA, Price VH, Duvic M.

J Am Acad Dermatol. 2011 Jan;64(1):53-63. doi: 10.1016/j.jaad.2009.12.056. Epub 2010 Oct 30.

PMID:
21036417
16.

A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.

López-Lerma I, Estrach MT.

J Am Acad Dermatol. 2009 Aug;61(2):263-70. doi: 10.1016/j.jaad.2009.03.041.

PMID:
19615537
17.

Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.

Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH.

Arch Dermatol. 2007 Jan;143(1):45-50.

PMID:
17224541
18.

Lymphoma-associated hemophagocytic syndrome (LAHS) in advanced-stage mycosis fungoides/Sézary syndrome cutaneous T-cell lymphoma.

Blom A, Beylot-Barry M, D'Incan M, Laroche L.

J Am Acad Dermatol. 2011 Aug;65(2):404-10. doi: 10.1016/j.jaad.2010.05.029. Epub 2011 May 7. Review.

PMID:
21550694
19.

Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.

Lamberg SI, Green SB, Byar DP, Block JB, Clendenning WE, Epstein EH Jr, Fuks ZY, Golitz LE, Lorincz AL, Michel B, Roenigk HH Jr, Van Scott EJ, Vonderheid EC, Thomas RJ.

Cancer Treat Rep. 1979 Apr;63(4):701-7.

PMID:
376140
20.

[Clinical characteristics of mycosis fungoides and Sézary syndrome].

Krc L, Dobesová J, Bucek M, Dusek J, Macák J, Galuszková D, Jurysek O.

Vnitr Lek. 1997 May;43(5):285-9. Czech.

PMID:
9601850

Supplemental Content

Support Center